Janet DuBois Selected Research

Oxymetazoline

11/2018	Topical Oxymetazoline Cream 1.0% for Persistent Facial Erythema Associated With Rosacea: Pooled Analysis of the Two Phase 3, 29-Day, Randomized, Controlled REVEAL Trials
3/2018	Phase 2 Randomized, Dose-Ranging Study of Oxymetazoline Cream for Treatment of Persistent Facial Erythema Associated With Rosacea.
2/2018	Clinical Pharmacokinetics of Oxymetazoline Cream Following Topical Facial Administration for the Treatment of Erythema Associated With Rosacea.
1/2018	WITHDRAWN: Efficacy and safety of topical oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: findings from the 2 phase 3, 29-day, randomized, controlled REVEAL trials.
1/2018	Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the First REVEAL Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Janet DuBois Research Topics

Disease

5	Rosacea (Acne Rosacea) 11/2018 - 01/2018
5	Erythema 11/2018 - 01/2018
2	Actinic Keratosis 01/2022 - 11/2020
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Alopecia (Baldness) 01/2021
1	Seborrheic Keratosis 12/2020
1	Hyperhidrosis 06/2020
1	Hyperpigmentation 06/2019
1	Acne Vulgaris 06/2019
1	Dermatitis 01/2018
1	Headache (Headaches) 01/2018

Drug/Important Bio-Agent (IBA)

5	Oxymetazoline FDA Link 11/2018 - 01/2018
1	BF-200 ALAIBA 01/2022
1	tapinarofIBA 01/2022
1	antineoplaston A10 (A 10)IBA 01/2022
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022
1	protoporphyrin IXIBA 01/2022
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2022
1	Aminolevulinic Acid (Levulan)FDA Link 01/2022
1	Prostaglandins AIBA 01/2022
1	2- (2- (1- naphthoyl)- 8- fluoro- 3,4- dihydro- 1H- pyrido(4,3- b)indol- 5(2H)- yl)acetic acidIBA 01/2021
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 12/2020
1	SolutionsIBA 12/2020
1	Ointments (Pastes)IBA 11/2020
1	src-Family KinasesIBA 11/2020
1	tirbanibulinIBA 11/2020
1	TubulinIBA 11/2020
1	BromidesIBA 06/2020
1	Cholinergic Antagonists (Anticholinergics)IBA 06/2020
1	Immunoglobulin A (IgA)IBA 06/2019
1	Benzoyl Peroxide FDA LinkGeneric 06/2019
1	Adapalene (Differin)FDA LinkGeneric 06/2019

Therapy/Procedure

1	Photochemotherapy (Photodynamic Therapy) 01/2022
1	Aftercare (After-Treatment) 06/2019
1	Skin Care 06/2019